Search
for
Sort by
Research 30 of 375
- Off-Label Use of Botulinum Toxin in Dermatology—Current State of the Art
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Antiandrogens: Clinical applications
- “In-Flu-Enza and Out-Flew Hair:” Post-Epidemic Health and theImportance of the History of Epidemics
- Multiple sclerosis: Side effects of interferon beta therapy and their management
- Imiquimod-induced effluvium after intravaginal application for treatment of cervical intraepithelial neoplasia
- Side effects of methotrexate therapy in patients with rheumatoid arthritis
- Clinical features, therapeutic outcomes and recovery period of long COVID
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study
- Fatal Rapunzel Syndrome
- Imiquimod
- Dermatologic Changes Associated With Interleukin 2 Administration
- High dose interferon treatment in chronic hepatitis C.
- Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: Prospective, multicenter, real‐world data from a Greek registry
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management
- CUTANEOUS T-CELL LYMPHOMA
- Treatment of chronic type B hepatitis in Southeast Asia.
- P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- The efficacy and particular side effects of therapy peginterferon alpha-2a acute hepatitis C hemodialysed patients
- ESCITALOPRAM
- INTERFERONS IN DERMATOLOGY
- Long-term symptom profiles after COVID-19<i>vs</i>other acute respiratory infections: a population-based observational study (COVIDENCE UK)
- Cognitive, emotional, physical, and behavioral stress-related symptoms and coping strategies among university students during the third wave of COVID-19 pandemic
- ABS0613 BRAIN FOG – A FREQUENT, WORRYING AND UNDER TREATED SYMPTOM OF LUPUS IN PATIENT EXPERIENCE
- Insights About a Pandemic: Clinical Approach
- Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors
- HIV Symptom Clusters are Similar Using the Dimensions of Symptom Occurrence and Distress